{
    "nct_id": "NCT06273111",
    "official_title": "A Pilot Study Using Topical Statins to Treat Children With Infantile Hemangioma",
    "inclusion_criteria": "* Healthy children aged between 3 months and 5 years.\n* Newly diagnosed superficial IH or experiencing rebound growth with a superficial component.\n* Participants must possess at least one IH lesion with the longest diameter equal to or greater than 2 cm, located on any part of the body except the lips.\n* Participants must not have received any of the following treatments for their IH:\n\n  * Topical medical therapy within the past 2 weeks.\n  * Systemic medical therapy within the past 3 months.\n  * Laser treatment within the past 6 weeks.\n* Written informed consent from the parent(s)/guardian(s) of minor participants must be obtained before any study procedure is performed.\nHealthy volunteers allowed\nMust have minimum age of 3 Months\nMust have maximum age of 5 Years",
    "exclusion_criteria": "* IH is primarily characterized as subcutaneous, and deep, with minimal cutaneous involvement for evaluation.\n* IH with active ulceration.\n* IH to be treated involving the lips mainly.\n* Participants with concurrent skin conditions that may impede accurate clinical assessment of the IH.\n* Participants with hereditary or metabolic disorders requiring systemic statin therapy.\n* Participants who are allergic to statins, or other ingredients present in the topical medication.",
    "miscellaneous_criteria": ""
}